4. More Clinical Trials
Clinical trials were more prevalent as of 2019, with 250,000 in 2018 compared to 50,000 in 2008. Not only do more trials mean better chances of clinical breakthroughs, but participating patients have access to new treatments. Although cancer care during COVID-19 has likely had some negative impact on clinical trials, their future is promising.